Author: solutiawp

Explore New Horizons in Genome Editing with the help of GeneHumdi STSM 2023 travel grants!

2023 Short scientific mission open call

Call for Applications: Short-Term Scientific Missions (STSMs)

The GeneHumdi COST Action CA21113 is excited to announce its 1st Call for applications for Short-Term Scientific Missions (STSMs). We invite passionate researchers like you to seize this exceptional opportunity to enhance your scientific knowledge and contribute to the advancement of your respective fields within the realm of genome editing to treat human diseases.

Why Engage in Short-Term Scientific Missions (STSMs)?

The GeneHumdi board is pleased to introduce Short-Term Scientific Missions (STSMs) funded by the prestigious COST Action program. These missions are designed to foster collaboration, strengthen networks, and facilitate knowledge exchange among researchers. By participating in STSMs, you gain access to research institutions or laboratories in other COST countries, enabling you to learn new techniques, utilize advanced equipment and methods, and contribute to the scientific objectives of the Action. Embrace this unique opportunity to expand your horizons, establish fruitful collaborations, and make significant strides in your research endeavors.

Harness the Power of Top Gene Editing Research groups in Europe

Participants in the COST Action’s Short-Term Scientific Missions (STSMs) have the freedom to focus their work on research topics highlighted by each GeneHumdi Working Group (WGs). Additionally, you have the liberty to introduce innovative ideas that align with the objectives of our Action. Explore the detailed content and goals of each WG in the Action’s Memorandum of Understanding (MoU). By aligning your STSM proposal with the scope of the dedicated WGs, you can maximize the impact of your research while contributing meaningfully to the GeneHumdi mission and to your field.

Guidelines for Applicants:

Financial Support: Successful applicants will receive travel grants for four Short-Term Scientific Missions (STSMs) offered by GeneHumdi. It is the responsibility of the grantees to arrange their travel, accommodation, and other logistics. During this period, STSM grants are awarded up to a maximum of €4,000. We encourage applicants to review the Annotated Rules for COST Actions to understand the financial framework.

Duration: STSMs must be completed within the 1st Grant Period of the Action, which concludes in October 2023. While there is no maximum duration for visits, the minimum visit should be at least 5 days, including travel time.

Application Deadline: Submit your applications by June 18th, 2023. Notification of decisions will be made by June 30th, 2023.

Eligibility: STSM travel grants are open to researchers and innovators associated with a legal entity in a COST Full/Cooperative Member, Near Neighbour Country, or European RTD. While all eligible candidates are encouraged to apply, young researchers and innovators under the age of 40 are particularly encouraged to participate.

Application Instructions: To apply for an STSM, utilize the e-COST management tool. Please ensure that you possess an e-COST profile, as it is mandatory for all applicants.

Submission Requirements: Use the e-COST management tool to submit your request for an STSM. Alongside the necessary information provided on the website, applicants are required to upload specific documents in a single PDF file, including:

  • A brief CV highlighting your recent publications.
  • The STSM proposal, outlining your research objectives and methodology.
  • The requested budget in euros.
  • A confirmation letter from the host institution.

Check the full call requirements and application score here:   1st Call for applications for Short-Term Scientific Missions (STSMs)

Eligible Topics

Each STSM must be aligned with one of the following topics:

  • Topic 1: Mapping the existing endonuclease-Independ platforms (EIP) and their potential output in different applications, efficacy, specificity of the available endonucleases independent GE tools.
  • Topic 2: Mapping the existing endonuclease platforms (EIP) and their potential output in different applications, efficacy, specificity of the available endonucleases independent GE tools
  • Topic 3: Delivery methods used for GE of the different cell types that are used for clinical applications. non-viral systems, based on ribonucleoparticles (RNP) or plasmids, are the ex vivo systems of choice to deliver the GE complex into the target cells.
  • Topic 4: Delivery methods used for in vivo GE in different animal models and in clinical settings. Including comparison of efficacy and specificity data for different GE tools delivered by different methods in each tissue/organ of interest.
  • Topic 5: The establishment of a standardized pipeline for the unbiased identification and quantification of CRISPR off-target sites for therapeutic applications.
  • Topic 6: Assessment of recombination events in gene editing approaches
  • Topic 7: Comparison of the different constrains in the HDR-mediated gene editing in the most primitive HSPCs, and how the HDR may be enhanced.
  • Topic 8: The evaluation of different GE strategies to target Hematopoietic stem cells in Fanconi anaemia cells in vitro, the sickle cell disease and beta-thalassemia, collagen VI deficiency and Emery Derfuss muscular dystrophy.
  • Topic 9: Market research study and competitive analysis on gene editing based medicines including the following tasks: (i) Market opportunity. Target niche; (ii) Definition of targeted market, sales by category (product, territory, class and market share (sales peak, defining at least three different scenarios), positioning, market drivers and barriers.
  • Topic 10: The analyse of regulatory requirements for the commercialization of gene editing based medicines.

Question and inquiries

Please contact GeneHumdi:

1st GeneHumdi CA2113 STSM Call

GenE-Humdi CA21113 COST Action Launches First Call for Inclusive Target Countries Conference Grants

DNA

The Genome Editing to Treat Humans Diseases (GeneHumdi | COST Action CA21113) has launched its first call for Inclusive Target Countries Conference Grants (CGs). The aim of these grants is to encourage the participation of young members from Inclusiveness Target Countries (ITCs) and Near Neighbour Countries (NNCs) in the activities related to GenE-Humdi COST Action purpose and to improve the quality of scientific research and training in these regions. PhD students, young researchers, and innovators under the age of 40 who are affiliated with an institution located in an ITC country are eligible to apply for the grant.

Individuals attending an in-person conference could receive up to €2000. The Grant Awarding Committee of the Action will assess each application based on the conference’s context, sessions, scientific topics and relevance, and contribution to the Action’s strategic priorities and objectives. The ITC Conference Grants of this first call will be available within the first Grant Period of the Action, i.e., by 31 October 2023.

Applicants need to have an e-COST profile as all applications must be processed through the e-COST online management tool. The deadline for the first round of applications is May 28th for applicants willing to assist to events starting after June 15th, and a second round´s deadline is June 25th for events starting after July 22th. The ITC CGs committee will review all applications, and the evaluation of applications will take about two weeks. The committee reserves the right to grant an amount that is less than the requested sum. The successful applicant will receive a Grant Letter that specifies the approved amount and the conditions that must be met to receive the grant.

GeneHumdi participates and promotes several Genome Editing related events, please refer to the grant bases, for suggested events. After the event, the grantee must submit required reports and relevant documentation in e-COST within 30 days after the end date of the activity or 15 days after the end of the Grant Period. The grantee must report the outcome of the presentation of the accepted contribution, the certificate of attendance, and the program of the conference or book of abstracts/proceedings indicating the presentation, following the indications in the grant announce bases.

For additional information on the submission process, applicants may refer to the reference document here For more information on GenE-Humdi, please visit the official webpage. If you have any questions or inquiries, please contact:

New Funding Opportunity for Young ITC scientist
Scroll to top